# Safety-and-effectiveness Clinical Evaluation of Nanosecond-pulse Ablation for Atrial Fibrillation

> **NCT06039722** · NA · COMPLETED · sponsor: **Shenzhen Pulsecare Medical Technology Co., Ltd.** · enrollment: 166 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** Pulse ablation catheter

## Key facts

- **NCT ID:** NCT06039722
- **Lead sponsor:** Shenzhen Pulsecare Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-03
- **Primary completion:** 2024-08-29
- **Final completion:** 2024-08-29
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039722, "Safety-and-effectiveness Clinical Evaluation of Nanosecond-pulse Ablation for Atrial Fibrillation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06039722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*